An Analysis of the Effect of ABCA4 p.Asn1868Ile Genotypes on Retinal Structure in 26,558 Participants in the UK Biobank.


Journal

Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701

Informations de publication

Date de publication:
01 06 2023
Historique:
medline: 23 6 2023
pubmed: 21 6 2023
entrez: 21 6 2023
Statut: ppublish

Résumé

To determine whether the ABCA4 retinopathy-associated variant p.Asn1868Ile (c.5603A>T) is associated with retinal structure or subclinical disease among the general population. UK Biobank participants of European ancestry with available spectral-domain optical coherence tomography (OCT) passing quality control metrics and exome sequencing data were included. Regression analyses using both linear and recessive models tested for the association between the p.Asn1868Ile variant and total retinal thickness, clinically relevant segmented layer thicknesses, and visual acuity. Further regression analyses were performed with automated quality control metrics to determine if the p.Asn1868Ile variant is associated with poor quality or abnormal scans. Retinal layer segmentation and sequencing data for the p.Asn1868Ile variant were available for 26,558 participants, following exclusions. We identified no significant association between the p.Asn1868Ile variant and retinal thickness, any of the segmented layers, or visual acuity. There was also no significant difference for homozygous p.Asn1868Ile when tested under the assumption of a recessive model. No association was identified for any of the quality control metrics, and a χ2 test showed that participants with the p.Asn1868Ile variant were not more likely to be excluded during quality control due to poor quality scans (P = 0.56). The p.Asn1868Ile variant does not appear to affect the retinal structure or have pathogenic or subclinical effects on its own within the general population. The variant is likely to require other specific cis- or trans-acting modifying factors to cause ABCA4 retinopathy.

Identifiants

pubmed: 37342033
pii: 2785717
doi: 10.1167/iovs.64.7.31
pmc: PMC10291893
doi:

Substances chimiques

ABCA4 protein, human 0
ATP-Binding Cassette Transporters 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

31

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 206619_Z_17_Z
Pays : United Kingdom
Organisme : British Heart Foundation
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom

Références

Retina. 2010 Jan;30(1):6-15
pubmed: 20066766
Ophthalmology. 2014 Jan;121(1):162-172
pubmed: 23993787
Sci Rep. 2020 Dec 3;10(1):21093
pubmed: 33273512
Invest Ophthalmol Vis Sci. 2016 Sep 1;57(11):4668-78
pubmed: 27583828
BMJ Open. 2019 Feb 21;9(2):e025077
pubmed: 30796124
Ophthalmology. 2020 Oct;127(10):1384-1394
pubmed: 32423767
Hum Mol Genet. 2009 Mar 1;18(5):931-41
pubmed: 19074458
Invest Ophthalmol Vis Sci. 2018 Jul 2;59(8):3220-3231
pubmed: 29971439
Invest Ophthalmol Vis Sci. 2016 Nov 01;57(14):5963-5973
pubmed: 27820952
Sci Transl Med. 2014 Feb 19;6(224):224ed4
pubmed: 24553384
Invest Ophthalmol Vis Sci. 2012 Apr 30;53(4):2112-8
pubmed: 22427542
Hum Mutat. 2020 Nov;41(11):1944-1956
pubmed: 32845050
Nature. 2020 Oct;586(7831):749-756
pubmed: 33087929
Opt Express. 2010 Sep 27;18(20):21293-307
pubmed: 20941025
Nature. 2020 May;581(7809):434-443
pubmed: 32461654
Invest Ophthalmol Vis Sci. 2016 Oct 01;57(13):5186-5191
pubmed: 27699414
Invest Ophthalmol Vis Sci. 2018 Nov 1;59(13):5566-5568
pubmed: 30480704
J Hum Genet. 2020 Aug;65(8):657-665
pubmed: 32277175
Ophthalmology. 2016 Apr;123(4):829-40
pubmed: 26746598
Retina. 2018 Feb;38(2):403-415
pubmed: 28248825
Invest Ophthalmol Vis Sci. 2018 Mar 1;59(3):1599-1608
pubmed: 29625486
BMC Med Genomics. 2020 Aug 26;13(1):120
pubmed: 32843070
J Med Genet. 2017 Jun;54(6):404-412
pubmed: 28446513
Science. 1997 Sep 19;277(5333):1805-7
pubmed: 9295268
Invest Ophthalmol Vis Sci. 2011 Aug 05;52(9):6206-12
pubmed: 21330655
Invest Ophthalmol Vis Sci. 2001 May;42(6):1179-89
pubmed: 11328725
Invest Ophthalmol Vis Sci. 2013 Mar 05;54(3):1603-12
pubmed: 23361506

Auteurs

Mark J Simcoe (MJ)

Institute of Ophthalmology, University College London, London, United Kingdom.
NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and the UCL Institute of Ophthalmology, London, United Kingdom.
Department of Ophthalmology, King's College London, St Thomas' Hospital Campus, London, United Kingdom.
KCL Department of Twins Research and Genetic Epidemiology, London, United Kingdom.

Gavin Arno (G)

Institute of Ophthalmology, University College London, London, United Kingdom.
NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and the UCL Institute of Ophthalmology, London, United Kingdom.

Pirro G Hysi (PG)

Department of Ophthalmology, King's College London, St Thomas' Hospital Campus, London, United Kingdom.
KCL Department of Twins Research and Genetic Epidemiology, London, United Kingdom.

Tony Ko (T)

Topcon Healthcare Solutions, Inc., Oakland, New Jersey, United States.

Michel Michaelides (M)

Institute of Ophthalmology, University College London, London, United Kingdom.
NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and the UCL Institute of Ophthalmology, London, United Kingdom.

Christopher J Hammond (CJ)

Department of Ophthalmology, King's College London, St Thomas' Hospital Campus, London, United Kingdom.
KCL Department of Twins Research and Genetic Epidemiology, London, United Kingdom.

Praveen J Patel (PJ)

Institute of Ophthalmology, University College London, London, United Kingdom.
NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and the UCL Institute of Ophthalmology, London, United Kingdom.

Omar A Mahroo (OA)

Institute of Ophthalmology, University College London, London, United Kingdom.
NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and the UCL Institute of Ophthalmology, London, United Kingdom.
Department of Ophthalmology, King's College London, St Thomas' Hospital Campus, London, United Kingdom.
KCL Department of Twins Research and Genetic Epidemiology, London, United Kingdom.

Andrew R Webster (AR)

Institute of Ophthalmology, University College London, London, United Kingdom.
NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and the UCL Institute of Ophthalmology, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH